Expert Review of Neurotherapeutics

Papers
(The TQCC of Expert Review of Neurotherapeutics is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Where Art Thou O treatment for diabetic neuropathy: the sequel50
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men50
The relevance of cortical thickness in migraine sufferers and implications to therapy45
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?45
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 202533
Steps to manage treatment-refractory migraine in adults32
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options31
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis31
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?30
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives30
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease29
Advances in the treatment and management of frontotemporal dementia29
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review29
The latest developments with internet-based psychological treatments for depression28
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms27
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study27
Acute and long-term cognitive impairment following sepsis: mechanism and prevention25
Why is ADHD so difficult to diagnose in older adults?25
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents25
The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications24
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead24
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia24
Correction23
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor23
Hesitancies in primary headaches treatments23
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?22
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations22
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?22
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder21
Spinal automaticity of movement control and its role in recovering function after spinal injury21
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms20
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan19
Advances in the early diagnosis of amyotrophic lateral sclerosis19
Preferences, tailoring, and self-tailoring in internet-delivered treatments: lessons learned19
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension19
Mindfulness as a therapeutic option for obsessive-compulsive disorder19
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature19
Current use of neurotoxins for alleviating symptoms of cervical dystonia18
The impact of sleep apnea on epilepsy treatment outcomes18
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients18
Multimodal approaches to the treatment of personality disorder18
Diagnostic advances and challenges in meningioma18
Virtual reality technology in the treatment of anxiety – progress and future challenges18
The differential diagnosis of autism spectrum disorder in adults17
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review17
Illuminating the way: the role of bright light therapy in the treatment of depression17
Advances in gene therapy for high-grade glioma: a review of the clinical evidence17
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy17
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools16
A novel treatment option for intrajejunal levodopa administration16
Considerations for hormonal therapy in migraine patients: a critical review of current practice16
Daridorexant: exploring its role in the treatment of insomnia disorder16
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound16
Cross-national reflections on medicinal cannabis and depression16
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective16
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts15
Long-term outcomes in refractory status epilepticus15
Frontotemporal dementia. How to deal with its diagnostic complexity?15
Considering hearing loss as a modifiable risk factor for dementia15
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies15
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)15
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes15
Cognitive and motivational therapy for problematic alcohol use and alcohol use disorder in older adults: a systematic review14
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor14
Updated review of rescue treatments for seizure clusters and prolonged seizures14
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature14
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond14
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?13
Do people with bipolar disorder have a greater risk of dementia in later life?13
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability13
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions12
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis12
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease12
Therapeutic issues in Guillain–Barré syndrome12
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes12
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?12
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions12
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?12
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression11
Could self-reporting sleep duration become an important tool in the prediction of dementia?11
When and in what patient segments are low-intensity and remote interventions valuable for treating symptoms of post-concussion syndrome11
An update on the developments and challenges with the diagnosis and classification of autoimmune optic neuritis11
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence11
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper11
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?11
Bipolar disorder staging and the impact it has on its management: an update11
Developments in targeting calcitonin gene-related peptide11
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?11
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain 11
Stem cell therapy for patients with paraplegia: is there hope for the future?10
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review10
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations10
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”10
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease10
Long-term central nervous system (CNS) consequences of COVID-19 in children10
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome10
Rethinking the role of trazodone in the different depressive dimensions10
Contemporary perspectives in cerebral amyloid angiopathy10
What place does daridorexant have in the treatment of Binge-Eating Disorder?10
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions10
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications9
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease9
Learnings in developmental and epileptic encephalopathies: what do we know?9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions9
Tobacco use disorder and depression: emerging strategies and recommendations:9
Deep brain stimulation: new programming algorithms and teleprogramming9
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures9
Exploring the differential diagnosis of generalized diabetic peripheral neuropathy9
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis9
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis9
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?9
0.14191198348999